ARTRIOFIN® Injectable solution


Non-steroidal anti-inflammatory

Indicated in the relief of pain and inflammation in dogs. It is especially indicated in the relief of signs associated with canine osteoarthritis. It is also recommended in the control of post-operative pain associated with orthopedic and soft tissue surgeries (including intraocular surgery).

Technical Specification

Species


Dogs

Dosage form


Injectable solution

Therapeutic action


Non-steroidal anti-inflammatory

Composition


Each 1 mL of injectable solution contains:
Carprofen...............44 mg
Excipients q.s.p........1 mL

Indications


Indicated in the relief of pain and inflammation in dogs. It is especially indicated in the relief of signs associated with canine osteoarthritis. It is also recommended in the control of post-operative pain associated with orthopedic and soft tissue surgeries (including intraocular surgery).

Route od administration and dosage


Subcutaneous administration

  • Active ingredient dose: 4.4 mg / kg once a day or 2.2 mg / kg twice a day, for up to 5 days.
  • Product dose: 1 mL for every 10 kilos of weight once a day, or divided into two 0.5 mL doses for every 10 kilos of weight, every 12 hours, for up to 5 days.

In the control of post-operative pain, its administration is recommended 2 hours before the procedure.

Contraindications


- Do not administer to animals with hypersensitivity to Carprofen.
- Do not administer intramuscularly.
- Do not exceed the indicated dose.
- Do not administer to pregnant or lactating females

Special precautions for use


- Use with caution in dogs under 6 weeks of age, or in advanced age.
- Avoid its administration in dehydrated, hypovolemic or hypotensive patients, or those suffering from
of cardiovascular, renal or hepatic dysfunction.
- Avoid its concomitant administration with other anti-inflammatories (NSAIDs or corticosteroids).
- Keep out of the reach of children and pets.

Special precautions for the operator


Avoid accidental self-injection and skin contact.

Warnings


Keep out of the reach of children.

Adverse effects


Prolonged use of Artriofin®, solution for injection, can cause gastrointestinal lesions,
loss of appetite, vomiting or diarrhoea, which resolve after discontinuation of treatment. Can
A transient local reaction may occur at the injection site. could also occur
behavioral disturbances such as listlessness or lethargy, which have a low incidence (<2%) and
that resolve spontaneously once treatment is discontinued.

Observations


Special precautions for disposal of unused product or material from
disposal:
Empty containers can be discarded as household waste, without any special precaution.
Do not dispose of containers with product remains on the ground or watercourses. for products
expired or unused contact the manufacturing laboratory.

Conservation


Store at room temperature below 30°C. Do not refrigerate or freeze. Once open the
container, use within 12 weeks. Discard unused product after that period of
time.

Condition of sale


Sale under Veterinary Medical prescription.

Presentation


50 mL ampoule bottle

Prepared by


Laboratorio Drag Pharma Chile Invetec S.A.

Records


Chile: Reg. SAG N° 1801
Uruguay: Reg. MGAP N° A-4456
Perú: Registro SENASA F.99.01.I.0076
Costa Rica: Reg. N° MV-7193

Available for sale


Imported and Distributed in Uruguay by:
VIVAFIL S.A. RIO NEGRO 1107 Montevideo 
Uruguay, 
TEL 29001112
grupotecnovet@gmail.com
Director Técnico: DMTV Diego Cuadrado.

Imported and Distributed in Peru by:
Representaciones Durand SAC.
Av. Manuel Olguín N° 501 Oficina N° 604 
Santiago de Surco Lima.

You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).

Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian